Understanding OUR Cytokine-Based Immunotherapy Candidates Our Motivation extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, especially for cancers where therapy choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/cme-group-set-to-add-sol-futures/